Pacific Biosciences Of California (PACB) Shares Outstanding (2010 - 2026)

Pacific Biosciences Of California has reported Shares Outstanding for 17 years, with the latest figure at $310.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3.48% year-over-year to $310.5 million; the trailing twelve-month figure through Mar 2026 stood at $310.5 million (up 3.48% YoY), and the FY2025 full-year result was $302.0 million, up 2.56% from the prior year.
• Shares Outstanding for Q1 2026 stood at $310.5 million, up from $302.0 million in the prior quarter.
• The five-year high for Shares Outstanding was $310.5 million in Q1 2026, with the low at $224.3 million in Q1 2022.
• Average Shares Outstanding over 5 years is $268.0 million, with a median of $272.3 million recorded in 2024.
• Peak annual rise in Shares Outstanding reached 1914.42% in 2022, while the deepest fall reached 2.5% in 2022.
• Tracing PACB's Shares Outstanding over 5 years: stood at $226.5 million in 2022, then grew by 18.21% to $267.7 million in 2023, then grew by 9.96% to $294.4 million in 2024, then advanced by 2.56% to $302.0 million in 2025, then rose by 2.83% to $310.5 million in 2026.
• The last three Shares Outstanding figures came in at $310.5 million (Q1 2026), $302.0 million (Q4 2025), and $301.9 million (Q3 2025), per Business Quant data.

Peer Comparison